Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.4 BRL | +5.14% | +32.47% | +218.34% |
May. 16 | Biomm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 18 | Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil | MT |
Sales 2022 | 105M 20M | Sales 2023 | 118M 22.53M | Capitalization | 470M 89.56M |
---|---|---|---|---|---|
Net income 2022 | -92M -17.54M | Net income 2023 | -81M -15.44M | EV / Sales 2022 | 5.9 x |
Net Debt 2022 | 67.72M 12.91M | Net Debt 2023 | 125M 23.81M | EV / Sales 2023 | 5.03 x |
P/E ratio 2022 |
-5.37
x | P/E ratio 2023 |
-5.93
x | Employees | 130 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 33.88% |
1 day | +5.14% | ||
1 week | +32.47% | ||
Current month | +5.14% | ||
1 month | +0.16% | ||
3 months | +82.54% | ||
6 months | +204.13% | ||
Current year | +218.34% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Director of Finance/CFO | - | 19-04-15 | |
Luciano Vilela
CTO | Chief Tech/Sci/R&D Officer | - | 14-02-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 14-01-31 | |
Director/Board Member | 84 | 15-10-12 | |
Director/Board Member | 81 | 13-12-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 18.4 | +5.14% | 666,400 |
24-05-31 | 17.5 | +9.99% | 641,000 |
24-05-29 | 15.91 | +10.03% | 219,400 |
24-05-28 | 14.46 | +4.10% | 204,600 |
Delayed Quote Sao Paulo, June 03, 2024 at 04:07 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+218.34% | 446M | |
+15.55% | 121B | |
+12.66% | 107B | |
-2.53% | 24.82B | |
+1.19% | 22.48B | |
-9.81% | 18.32B | |
-42.28% | 16.33B | |
-18.92% | 15.31B | |
+6.19% | 14.08B | |
+28.83% | 11.74B |
- Stock Market
- Equities
- BIOM3 Stock